TrialFrontiers in endocrinology2022

A Randomized Controlled Phase 3 Study on the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Idiopathic Short Stature.

Jinna Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.